News
-
-
-
PRESS RELEASE
Vision Marine Technologies Reports $8.2M in 7-Week Boat Sales, Highlighting Post-Acquisition Growth Impact
Vision Marine Technologies reports significant sales performance increase following acquisition of Nautical Ventures Group Inc., with boosted boat sales revenue and reduced floor plan liabilities -
-
PRESS RELEASE
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
MIRA Pharmaceuticals announces the acceptance of a manuscript in Frontiers in Pharmacology detailing Ketamir-2's efficacy in neuropathic pain, supporting Phase 2a trials by 2025 -
-
-
-
-